A novel candidate compound with urethane structure for anticancer drug development

Current Drug Discovery Technologies

Volumn 4, Issue 2, 2007, Pages 69-76

  Matsuoka, Atsuko ^a   Isama, Kazuo ^a   Tanimura, Susumu ^b   Kohno, Michiaki ^b   Yamori, Takao ^c  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Diethyl 4,4 methylenebis(N phenylcarbamate); JFCR39; Polyploidy; Tubulin inhibitor; Urethane model compounds

Indexed keywords

1,6 BIS(ETHOXYCARBONYLAMINO)HEXANE; 2,4 BIS(ETHOXYCARBONYLAMINO)TOLUENE; ANTINEOPLASTIC AGENT; COLCHICINE; DIETHYL 4,4' METHYLENE BIS(N PHENYLCARBAMATE); NAVELBINE; NERVE GROWTH FACTOR; PACLITAXEL; POLYURETHAN; UNCLASSIFIED DRUG; URETHAN DERIVATIVE; VINCRISTINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL LINE; CHINESE HAMSTER; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; HYDROLYSIS; MICRONUCLEUS; MITOSIS; MULTINUCLEAR CELL; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CRICETINAE; CRICETULUS; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MUTAGENICITY TESTS; URETHANE;

EID: 34548421554     PISSN: 15701638     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016307781483450     Document Type: Article

References (16)

1. Nakamura A., Kawasaki Y., Takada K., Aida Y., Kurokawa Y., Kojima S., Shintani H., Matsui M. et al.: Difference in tumor incidence and other tissue responses to polyetherurethanes and polydimethylsiloxane in long-term subcutaneous implantation into rats. J. Biomed. Mater. Res. 26, 631, (1992).
2. Tsuchiya T., Nakaoka R., Degawa H., Nakamura A.: Studies on the mechanisms of tumorigenesis induced by polyetherurethanes in rats: Leachable and biodegradable oligomers involving the diphenyl carbamate structure acted as an initiator on the transformation of Balb 3T3 cells. J. Biomed. Mater. Res. 31, 299, (1996).
3. Tsuchiya T., Hata H., Nakamura A.: Studies on the tumor-promoting activity of biomaterials: Inhibition of metabolic cooperation by polyetherurethane and silicone. J. Biomed. Mater. Res. 29, 113, (1995).
4. Isama K., Kojima S., Nakamura A.: Phase studies of a urethane model compound and polyether macroglycols by infrared spectroscopy and the relationship between eutectic composition of soft segment and blood compatibility. J. Biomed. Mater. Res. 27, 539, (1993).
5. Ishidate M.Jr., Odashima S.: Chromosome test with 134 compounds on Chinese hamster cells in vitro-a screening for chemical carcinogens. Mutat. Res. 48, 337, (1977).
6. Matsuoka A., Hayashi M., Ishidate M.Jr.: Chromosomal aberration tests on 29 chemicals combined with S9 mix in vitro. Mutat. Res. 66, 277, (1979).
7. Matsuoka A., Sofuni T., Miyata N., Ishidate M.Jr.: Clastogenicity of 1-nitropyrene, dinitropyrenes, fluorene, and mononitrofluorenes in cultured Chinese hamster cells. Mutat. Res. 259, 103, (1991).
8. Matsuoka A., Yamazaki N., Suzuki T., Hayashi M., Sofuni T.: Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res. 272, 223, (1993).
9. Matsuoka A., Matsuura K., Sakamoto H., Hayashi M., Sofuni T.: A proposal for a simple way to distinguish aneugens from clastogens in the in vitro micronucleus test. Mutagenesis 14, 385, (1999).
10. Yamori T., Matsunaga A., Sato S., Yamazaki K., Komi A., Ishizu K., Mita I., Edatsugi H. et al.: Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res. 59, 4042, (1999).
11. Yaguchi S., Fukui Y., Koshimizu I., Yoshimi H., Matsuno T., Gouda H., Hirono S., Yamazaki K. et al.: Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. J. Natl. Cancer Inst. 98, 545, (2006).
12. Paull K.D., Shoemaker R.H., Hodes L., Monks A., Scudiero D.A., Rubinstein L., Plowman J., Boyd M.R.: Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. 81, 1088, (1989).
13. Kohno M., Watanabe K., Tanimura S.: Application of NGF/PC12 cell system for the screening of tubulin inhibitors. Jpn. J. Cancer Chemother. 31, 501, (2004).
14. Yamori T.: Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics. Cancer Chemother. Pharmacol. 52 (Suppl. 1), 74, (2003).
15. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D.: Molecular biology of the cell, Third edition, Garland Publishing: New York, (1994).
16. Sofuni T. (Ed): Data book of chromosomal aberration test in vitro, revised edition 1998, L.I.C.: Tokyo, (1998).